ARTICLE | Company News
Helsinn, Specialised Therapeutics Australia sales and marketing update
November 8, 2010 8:00 AM UTC
Helsinn Healthcare granted Specialised Therapeutics exclusive rights to commercialize Aloxi palonosetron in Australia and New Zealand. Further deal terms were not disclosed. Following the deal, Speci...